Position in ZTS
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$355,126,482
+$11,060,369 QoQ
Shares Held
3,004,200
+9.9% QoQ
Ownership
0.717%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Swedbank AB holds $732,986,628 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (48.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
3,004,200 | $355,126,482 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
327,122 | $193,976,803 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
1,228,743 | $93,200,156 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
579,429 | $76,333,976 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
380,266 | $11,453,611 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
95,000 | $2,895,600 |
All Filings in ZTS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $355,126,482 | 3,004,200 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $344,066,113 | 2,734,590 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $356,565,452 | 2,436,888 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $236,933,275 | 1,519,290 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $312,051,682 | 1,915,250 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $354,051,224 | 1,812,116 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $337,406,580 | 1,946,277 | Shares | Defined | 2024-07-11 | |
| 2023-12-31 | $186,592,019 | 945,392 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $124,202,582 | 713,890 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $34,025,424 | 197,581 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $32,174,682 | 193,311 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $30,090,085 | 205,323 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $31,178,713 | 210,255 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $35,438,217 | 206,168 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $46,027,463 | 244,061 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $57,564,480 | 235,891 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $46,459,449 | 239,309 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $44,921,891 | 241,049 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $36,099,770 | 229,234 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||